XML 43 R19.htm IDEA: XBRL DOCUMENT

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2012
Subsequent Events [Abstract]
Subsequent Events	NOTE 15. SUBSEQUENT EVENTS On July 31, 2012, the Company submitted a New Drug Application (NDA) for Serada for the treatment of menopausal hot flashes to the FDA.